gadolinium has been researched along with Multiple Sclerosis in 309 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (0.97) | 18.7374 |
| 1990's | 87 (28.16) | 18.2507 |
| 2000's | 63 (20.39) | 29.6817 |
| 2010's | 89 (28.80) | 24.3611 |
| 2020's | 67 (21.68) | 2.80 |
| Authors | Studies |
|---|---|
| Gaj, S; Nakamura, K; Ontaneda, D | 1 |
| Carare, RO; Galea, I; Gawne-Cain, M; Varatharaj, A; Weller, RO | 1 |
| Großmann, A; Hauenstein, K; Kühn, I; Maschke, H; Storch, A; Walter, U; Weber, MA; Zettl, UK | 1 |
| Auger, C; Rovira, À | 1 |
| Okar, SV; Reich, DS | 1 |
| Culpepper, W; Jin, S; Lee-Wilk, T; Leekoff, M; Wallin, M | 1 |
| Arnold, DL; Collins, DL; Dadar, M; Mahmoud, S; Maranzano, J; Narayanan, S | 1 |
| Barkhof, F; Brouwer, I; Bø, L; Kerklingh, E; Lie, IA; Myhr, KM; Torkildsen, Ø; van Nederpelt, DR; Vrenken, H; Wesnes, K | 1 |
| Bilello, M; Cook, TS; Davtyan, K; Jacobs, DA; Loevner, LA; Mamourian, AC; Mattay, GS; Mattay, RR; Rudie, JD; Schindler, M; Schnall, MD | 1 |
| Dincic, E; Georgievski-Brkic, B; Jovanovski, A; Koprivsek, K; Kostic, D; Kostic, S; Misovic, M; Rancic, N | 1 |
| Barkhof, F; Bulte, JWM; Thomas, AM | 1 |
| Lin, M; Luo, J; Shi, S; Zhang, J; Zhang, Y | 1 |
| Camara-Lemarroy, C; Cerchiaro, G; Greenfield, J; Kuhle, J; Leppert, D; Li, DK; Metz, L; Silva, C; Traboulsee, A; Willemse, E; Yong, VW | 1 |
| Bisecco, A; Capuano, R; d'Ambrosio, A; Di Filippo, M; Fiacca, A; Gaetani, L; Gallo, A; Gentili, L; Guercini, G; Mancini, A; Parnetti, L; Tedeschi, G | 2 |
| Delgado-Marín, JL; Iniesta-Martínez, F; Jimenez-Veiga, J; León-Hernández, A; Meca-Lallana, JE; Millán-Pascual, J; Morales-Ortiz, A; Tejero-Martín, AB; Valero-López, G; Zamarro-Parra, J | 1 |
| Alvarez, E; Bosco, JA; Cree, BAC; Cutter, G; Fox, E; Hartung, HP; Hsu, Y; Huang, D; Lee, L; Miskin, HP; Mok, K; Power, SA; Qian, P; Robertson, D; Selmaj, K; Steinman, L; Weiss, MS; Wray, S; Wynn, D; Xu, Y | 1 |
| Christine, LF; Grouin, JM; Kobelt, G; Labauge, P; Laplaud, D; Lotz, M; Manchon, E; Moreau, T; Pau, D; Vukusic, S | 1 |
| Abbadessa, G; Avolio, C; Barone, S; Bonavita, S; Callari, G; Cellerino, M; D'Amico, E; Ferraro, D; Granella, F; Inglese, M; Lus, G; Messina, C; Patti, F; Signoriello, E; Sola, P; Tsantes, E; Valentino, P; Zanghì, A | 1 |
| Barnett, MH; Graham, SL; Klistorner, A; Klistorner, S; Parratt, J; Yiannikas, C | 1 |
| Batlle-Nadal, J; Blanco, Y; Brieva-Ruiz, L; Cano-Orgaz, A; Capellades, J; Carmona, O; Gea, M; Hervás-García, JV; Martín-Aguilar, L; Massuet-Vilamajó, A; Moral, E; Presas-Rodriguez, S; Ramió-Torrentà, L; Ramo-Tello, C; Rovira, À; Tintoré, M | 1 |
| Rubinstein, D | 1 |
| Mahler, JV; Silva, GD | 1 |
| Asadollahzade, E; Ebadi, Z; Ghadiri, F; Moghadasi, AN | 1 |
| Cohen, JA; Jones, SE; Lowe, MJ; McGinley, MP; Nakamura, K; Ontaneda, D; Ruggieri, PM | 1 |
| Affinito, G; Brescia Morra, V; Caliendo, D; Carotenuto, A; Dallera, G; Moccia, M; Palladino, R; Petracca, M; Triassi, M | 1 |
| Hashimoto, T; Hatano, T; Matsuyoshi, A; Miyata, T; Shiraishi, W; Yamada, Y | 1 |
| Bergendal, Å; Cananau, C; Fink, K; Forslin, Y; Fredrikson, S; Granberg, T; Ouellette, R; Sjöström, H; Wiberg, MK | 1 |
| Berthele, A; Bussas, M; El Husseini, M; Gasperi, C; Grahl, S; Grundl, L; Harabacz, L; Hemmer, B; Kirschke, J; Mühlau, M; Pineker, V; Pongratz, V; Schmidt, P; Sepp, D; Wiestler, B; Zimmer, C | 1 |
| Cola, G; Dianzani, C; Landi, D; Mallio, CA; Marfia, GA; Parillo, M; Perrella, E; Quattrocchi, CC; Spani, F | 1 |
| Brescia Morra, V; Brunetti, A; Cocozza, S; Criscuolo, C; Elefante, A; Falco, F; Lanzillo, R; Moccia, M; Monti, S; Palma, G; Petracca, M; Pontillo, G; Scaravilli, A; Tedeschi, E; Tranfa, M | 1 |
| Bickert, A; Bittner, S; Foerch, C; Mann, U; Mayer, C; Schaefer, JH; Schaller-Paule, MA; Steffen, F; Wenger, K; Yalachkov, Y | 1 |
| Deiva, K; Maillart, E; Maurey, H; Saponaro, AC; Tully, T | 1 |
| Becich, MJ; Chitnis, T; da Costa, FR; El Ayoubi, NK; Foley, J; Gaitan-Walsh, P; Gehman, VM; Ghoreyshi, A; Ionete, C; Jalaleddini, K; Keshavan, A; Khoury, SJ; Lokhande, H; Paul, A; Qureshi, F; Saleh, F; Saxena, S; Weiner, H; Zhang, F | 1 |
| Ahmed, SF; Al-Hashel, J; AlMojel, M; Alroughani, R | 1 |
| Cluse, F; Cotton, F; Ducray, F; Durand-Dubief, F; Fenouil, T; Marignier, R; Vukusic, S | 1 |
| Alikılıç, D; Anlar, B; Bektaş, Ö; Çavuşoğlu, D; Dilek, TD; Gültutan, P; Güngör, M; Güngör, O; Kanmaz, S; Kara, B; Karaoğlu, P; Öncel, İ; Orak, SA; Saltık, S; Teber, S; Tekgül, H; Yıldırım, M; Yılmaz, D; Yılmaz, S; Yılmaz, Ü | 1 |
| Hu, R; Lava, NS; Sadigh, G; Saindane, AM; Waldman, AD | 1 |
| Cutter, G; Koch, MW; Mostert, J; Uitdehaag, B | 1 |
| Barillot, C; Bonneville, F; Brisset, JC; Cotton, F; Dousset, V; Durand-Dubief, F; Guttmann, C; Hannoun, S; Kremer, S; Tourdias, T; Vukusic, S | 1 |
| Berthele, A; Bussas, M; Grahl, S; Hemmer, B; Kirschke, JS; Mühlau, M; Pongratz, V; Zimmer, C | 1 |
| Greenfield, J; Koch, MW; Liu, WQ; Metz, L; Mostert, J | 1 |
| Bazzurri, V; Crisi, G; Curti, E; Fiore, A; Ganazzoli, C; Granella, F; Puci, F; Tsantes, E | 1 |
| Aydınlı, N; Bektaş, G; Çalışkan, M; Özkan, MU; Özmen, M; Sencer, S; Uzunhan, TA; Yıldız, EP | 1 |
| Coronado, I; Gabr, RE; Narayana, PA | 1 |
| Bakshi, R; Benkert, P; Bjornevik, K; Chitnis, T; Gonzalez, CT; Guttmann, C; Healy, BC; Kuhle, J; Leppert, D; Paul, A; Rosso, M; Saxena, S; Weiner, HL | 1 |
| Rovira, À; Wattjes, MP | 1 |
| Granziera, C; Reich, DS | 1 |
| Maghzi, AH; Sicotte, NL; Waubant, E | 1 |
| Ghaedian, M; Ghaedian, T; Zarei, F | 1 |
| Engisch, R; Katz, JD; Lathi, ES; Napoli, SQ; Samaan, S; Schwartz, ED; Sloane, JA; Titelbaum, DS | 1 |
| Cai, K; Chen, Q; Chen, W; Lutz, SE; Shaghaghi, M; Ye, H; Zhang, Y | 1 |
| Gauthier, SA; Kuceyeski, A; Nguyen, TD; Ryan, SM; Sweeney, EM; Wang, Y; Zexter, L; Zhang, S | 1 |
| Allison, JB; Azalone, E; Bazylewicz, M; Johnson, T; Johnston, G; Solomon, AJ; Ulano, A | 1 |
| Altieri, M; Bernitsas, E; Brenner, MJ; Di Stadio, A; Dipietro, L; Kaski, D; Messineo, D; Ralli, M | 1 |
| Croese, T; Dalla Costa, G; Filippi, M; Furlan, R; Gelibter, S; Martinelli, V; Orrico, M; Pisa, M; Preziosa, P; Sangalli, F | 1 |
| Kesavadas, C; Nair, SS; Sabarish, S; Tandon, V; Thomas, B; Vinayagamani, S | 1 |
| Dai, X; Li, W; Luo, K; Zeng, Y; Zhang, H; Zhang, Q | 1 |
| Capra, R; Galgani, S; Gasperini, C; Haggiag, S; Montalban, X; Pozzilli, C; Prosperini, L; Río, J; Rovira, À; Sastre-Garriga, J; Tintoré, M; Tortorella, C | 1 |
| Agnello, F; Banco, A; Galia, M; Iaia, A; Midiri, M; Sparacia, G | 1 |
| Choi, S; Harrison, DM; Hua, J; Spini, M | 1 |
| Shegay, MM; Shimanovsky, DN | 1 |
| Brisset, JC; Cotton, F; Vukusic, S | 1 |
| Banwell, B; Barkhof, F; Ciccarelli, O; de Stefano, N; Enzinger, C; Fazekas, F; Filippi, M; Frederiksen, J; Gasperini, C; Hacohen, Y; Kappos, L; Li, DKB; Mankad, K; Montalban, X; Newsome, SD; Oh, J; Palace, J; Reich, DS; Rocca, MA; Rovira, À; Sastre-Garriga, J; Tintoré, M; Traboulsee, A; Vrenken, H; Wattjes, MP; Yousry, T | 1 |
| Aime, S; Atlante, S; Bertolotto, A; Buffo, A; Di Gregorio, E; Furlan, C; Gianolio, E; Montarolo, F; Parolisi, R | 1 |
| Allen, CM; Chataway, J; Evangelou, N; Fernandes, L; Ford, HL; Tallantyre, E; Williams, T | 1 |
| Brod, SA | 1 |
| Andermatt, S; Cattin, P; Papadopoulou, A; Radue, EW; Sprenger, T | 1 |
| Avsenik, J; Lamot, U; Šega, S; Šurlan Popovič, K | 1 |
| Abolhasani Foroughi, A; Heidari, H; Khorsand, A; Nazeri, M; Nikseresht, A; Salahi, R | 1 |
| Aspelin, P; Bergendal, G; Forslin, Y; Fredrikson, S; Granberg, T; Hashim, F; Kristoffersen-Wiberg, M; Martola, J; Shams, S | 1 |
| Al-Dasuqi, K; Askin, G; Delgado, D; Gupta, A; Wang, Y; Xia, F; Zhao, Y | 1 |
| Gralla, J; Heldner, MR; Kamm, CP; Kellner-Weldon, F; Locher, C; Raabe, A; Schucht, P; Slotboom, J; Verma, RK; Wiest, R | 1 |
| Eisele, P; Gass, A; Konstandin, S; Ong, M; Schad, LR; Schoenberg, SO; Szabo, K; Zöllner, F | 1 |
| Arnold, DL; Cadavid, D; Cook, S; Maranzano, J; Nakamura, K; Narayanan, S; Rudko, DA; Wolansky, L | 1 |
| Fiehler, J; Heesen, C; Kutzner, D; Schneider, T; Sedlacik, J; Siemonsen, S; Stellmann, JP; Thaler, C | 1 |
| Barile, A; Di Cesare, E; Marsecano, C; Michelini, G; Perri, M; Splendiani, A; Vellucci, V | 1 |
| Bannier, E; Barillot, C; Combès, B; Commowick, O; Edan, G; Ferré, JC; Kerbrat, A; Maarouf, A; Ranjeva, JP; Tourbah, A | 1 |
| Abounasr, A; Bevan, CJ; Bischof, A; Cree, BA; Demuth, S; Eggers, EL; Greenfield, AL; Hauser, SL; Henry, RG; Kazer, M; Leitner, E; Michel, BA; Pierson, NS; von Büdingen, HC; Wang, SZ; Wilson, MR; Wu, H | 1 |
| Chataway, J | 1 |
| Clarelli, F; Colombo, B; Comi, G; Esposito, F; Ferrè, L; Filippi, M; Martinelli Boneschi, F; Martinelli, V; Moiola, L; Radaelli, M; Rocca, MA; Sangalli, F; Sferruzza, G; Storelli, L | 1 |
| Bergsland, N; Dwyer, MG; Hagemeier, J; Hojnacki, D; Kolb, C; Ramasamy, DP; Schweser, F; Weinstock-Guttman, B; Zivadinov, R | 2 |
| Darmon-Kern, E; Desché, P; Lancelot, E; Laurent, AC; Raynaud, JS | 1 |
| Splendiani, A | 1 |
| Behzadi, AH; Gupta, A; Prince, MR | 1 |
| Fukazawa, T; Kawashima, A; Miyazaki, Y; Niino, M; Sato, K; Yamada, M | 1 |
| Alvarez, E; Corboy, JR; Honce, JM; Nair, K; Sillau, S; Vollmer, B; Vollmer, T | 1 |
| Baalbaki, M; El Ayoubi, NK; Haddad, R; Hannoun, S; Hourani, R; Khoury, SJ; Saaybi, S; Yamout, BI | 1 |
| Achiron, A; Friedlander, A; Givon, U; Hoffman, C | 1 |
| Adamiak, Z; Golubczyk, D; Holak, P; Janowski, M; Kalkowski, L; Kedziorek, D; Maksymowicz, W; Malysz-Cymborska, I; Milewska, K; Walczak, P | 1 |
| Asmar, K; Bou-Fakhredin, R; El-Merhi, F; Naffaa, L; Saade, C; Yousem, DM | 1 |
| Brod, SA; Lincoln, JA; Nelson, F | 1 |
| Audoin, B; Desplat-Jégo, S; Khrestchatisky, M; Maarouf, A; Pelletier, J; Ranjeva, JP; Ranjeva, MP; Stephan, D | 1 |
| Berthele, A; Bussas, M; Eichinger, P; Hemmer, B; Hoshi, MM; Kirschke, J; Mühlau, M; Pongratz, V; Schön, S; Wiestler, B; Wiestler, H; Zhang, H; Zimmer, C | 1 |
| Saindane, AM | 1 |
| Bilello, M; Cook, TS; Loevner, LA; Mamourian, AC; Mattay, RR; Rudie, JD; Schindler, M; Schnall, MD; Steingall, S | 1 |
| Bellanger, G; Biotti, D; Bonneville, F; Brassat, D; Catalaa, I; Ciron, J; Cognard, C; Dumas, H; Ferrier, M; Gramada, R; Lerebours, F; Meluchova, Z; Patsoura, S | 1 |
| Akiyama, Y; Awai, K; Hashizume, A; Kaichi, Y; Karlowee, V; Kolakshyapati, M; Kurisu, K; Maruyama, H; Ochi, K; Sugiyama, K; Takano, M; Takayasu, T; Ueno, H; Yamasaki, F | 1 |
| Amaral, LLFD; Fragoso, DC; Rocha, AJD | 1 |
| Deichmann, R; Gracien, RM; Hattingen, E; Hirschmann, M; Jurcoane, A; Mayer, C; Schmidt, C; Volz, S; Wagner, M; Ziemann, U | 1 |
| Fisher, E; Reich, DS | 1 |
| Armspach, JP; de Sèze, J; Dietemann, JL; Jeantroux, J; Kremer, S; Lamy, J; Magnus, A; Oesterle, H; Trunet, S | 1 |
| Ciach, A; Selmaj, K; Siger, M; Szczepanik, M; Walczak, A | 1 |
| Cocco, E; Coghe, G; Fenu, G; Frau, J; Lorefice, L; Marrosu, MG; Melis, M; Mura, M | 1 |
| Brieva, L; Cano, A; Carmona, O; Costa, J; Giner, P; Grau-López, L; Martínez-Cáceres, E; Massuet, A; Montalbán, X; Nos, C; Ramió i Torrenta, L; Ramo-Tello, C; Rovira, A; Saiz, A; Tintoré, M; Torres, F | 1 |
| Barreto, AD; Brod, SA; Cohen, AM; Hasan, KM; Heimbigner, JH; Kramer, LA; Narayana, PA; Wolinsky, JS | 1 |
| Chen, W; Comunale, J; Gauthier, SA; Gupta, A; Liu, T; Pei, M; Pitt, D; Wang, S; Wang, Y | 1 |
| Arbel, T; Arnold, DL; Collins, DL; Karimaghaloo, Z; Rivaz, H | 2 |
| Biassou, NM; Butman, JA; Li, N; Pham, DL; Reich, DS; Sati, P; Thomasson, DM | 1 |
| Agius, M; Chin, P; Grinspan, A; Hashmonay, R; Meng, X | 1 |
| Bannier, E; Barillot, C; Berry, I; Commowick, O; Crimi, A; Edan, G; Ferré, JC; Maarouf, A; Ranjeva, JP; Tourbah, A | 1 |
| Bensa, C; Deschamps, R; Gout, O; Gueguen, A; Heran, F; Moulignier, A; Roux, P; Savatovsky, J | 1 |
| Chen, SY; Chen, YC; Chu, CM; Hsu, CC; Hsu, WL; Kao, HW; Lin, WC; Liu, DW; Lo, CP | 1 |
| Battaglini, M; De Stefano, N; Grove, RA; Matthews, PM; Rossi, F; Stromillo, ML; Whitcher, B | 1 |
| Kobayashi, M; Shibata, N; Shimizu, Y; Uchiyama, S | 1 |
| Domowicz, M; Jurewicz, A; Selmaj, K; Zaleski, K | 1 |
| Friede, T; Heesen, C; Siemonsen, S; Stellmann, JP; Stürner, KH; Young, KL | 1 |
| Cendes, F; Damasceno, A; Damasceno, BP | 1 |
| Bharatha, A; Chakraborty, S; Freedman, MS; Girard, JM; Giuliani, F; Létourneau-Guillon, L; Li, DK; Lysack, JT; Marriott, JJ; Metz, LM; Morrow, SA; O'Connor, PW; Oh, J; Sharma, M; Traboulsee, A; Vandorpe, RA; Vertinsky, TA; von Riedemann, S; Wadhwa, VS | 1 |
| Abakumova, TO; Chekhonin, VP; Gusev, EI; Nukolova, NV | 1 |
| Barletta, VT; Contessa, GM; De Angelis, F; De Giglio, L; Gurreri, F; Marinelli, F; Pantano, P; Piattella, MC; Pozzilli, C; Prosperini, L; Tomassini, V | 1 |
| Stojanov, DA | 1 |
| Barkhof, F; Daams, M; Duan, Y; Hahn, HK; Li, K; Liu, Y; Lukas, C; Steenwijk, MD; Versteeg, A; Vrenken, H; Wattjes, MP; Weiler, F | 1 |
| Abela, E; Heldner, MR; Kamm, CP; Kellner-Weldon, F; Locher, C; Slotboom, J; Verma, RK; Weisstanner, C; Wiest, R; Zbinden, M | 1 |
| Allen, M; Carnì, M; d'Ambrosio, A; Fanelli, F; Foster, C; Gallo, A; Pantano, P; Petsas, N; Pozzilli, C; Sbardella, E; Tomassini, V; Tona, F; Wise, RG | 1 |
| Kinoshita, M; Nakahara, K; Tanaka, M | 1 |
| Badr, S; Benadjaoud, MA; Chechin, D; Hodel, J; Lebert, P; Leclerc, X; Outteryck, O; Pruvo, JP; Vermersch, P | 1 |
| Arnold, DL; Brown, RA; Cadavid, D; Cook, S; Narayanan, S; Stikov, N; Wolansky, L | 1 |
| Lu, Y; Zhan, Q; Zhao, J | 1 |
| Goischke, HK | 1 |
| Bendszus, M; Breckwoldt, MO; Diem, R; Gradl, J; Hähnel, S; Heiland, S; Hielscher, T; Platten, M; Wick, W; Wildemann, B | 1 |
| Abdoli, M; Chakraborty, S; Freedman, MS; MacLean, HJ | 1 |
| Debouverie, M; Edan, G; Gout, O; Le Page, E; Malikova, I; Ory, S; Pelletier, J; Roullet, E; Vermersch, P | 1 |
| Barkhof, F; Knol, D; Uitdehaag, B; van den Elskamp, I | 1 |
| Banwell, BL; Branson, HM; Callen, DJ; Li, DK; Lotze, T; Shroff, MM; Stephens, D | 1 |
| Daumer, M; Ebers, GC; Hintzen, R; Morrissey, S; Neuhaus, A | 1 |
| Hofer, S; Kollias, S; Weller, M | 1 |
| Koch-Henriksen, N | 1 |
| Barkhof, F; Filippi, M; Frederiksen, JL; Huerga, E; Langkilde, A; Miller, D; Miszkiel, K; Montalban, X; Polman, C; Rovaris, M; Rovira, A; Sastre-Garriga, J; Swanton, J; Tintoré, M | 1 |
| Arnold, DL; Fox, RJ | 1 |
| Kinkel, RP; Kremenchutzky, M; O'Connor, P | 1 |
| Adachi, S; Hattori, N; Kawajiri, S; Moritani, T; Motoi, Y; Saiki, S; Sato, T; Sekine, T; Tomizawa, Y; Ueno, Y; Yokoyama, K | 1 |
| Cadavid, D; Pachner, AR; Skurnick, J; Wolansky, L | 1 |
| Annovazzi, P; Comi, G; Falini, A; Filippi, M; Martinelli Boneschi, F; Martinelli, V; Pulizzi, A; Rocca, MA; Rodegher, M; Scotti, R; Sormani, MP | 1 |
| Barkhof, F; Geurts, JJ; Guttmann, CR; Knol, DL; Meier, DS; Moraal, B; Pouwels, PJ; Uitdehaag, BM; van den Elskamp, IJ; van Schijndel, RA; Vrenken, H | 1 |
| Cutter, G; Healy, BC; Ikle, D; Macklin, EA | 1 |
| Arbel, T; Arnold, DL; Collins, DL; Francis, SJ; Karimaghaloo, Z; Shah, M | 2 |
| Bernardi, G; Bernardini, S; Buttari, F; Castelli, M; Centonze, D; Codecà, C; Koch, G; Kusayanagi, H; Mataluni, G; Monteleone, F; Mori, F; Motta, C; Rossi, S; Sancesario, G; Studer, V | 1 |
| Anagnostopoulos, A; Fassas, A; Kapinas, K; Kazis, A; Kimiskidis, VK; Sakellari, I; Sotirakoglou, K; Tsimourtou, V | 1 |
| Hidaka, T; Hirayama, T; Ikeda, K; Ito, H; Iwasaki, Y; Kano, O; Kawabe, K; Sekine, T; Takazawa, T; Yoshii, Y | 1 |
| Araújo, D; Arnold, DL; Jelescu, IO; Leppert, IR; Narayanan, S; Pike, GB | 1 |
| Fujima, N; Fukaura, H; Ishizuka, N; Kudo, K; Kudo, M; Sasaki, M; Suzuki, M; Takahashi, J; Takahashi, S; Terayama, Y; Uwano, I; Yonezawa, H | 1 |
| Barros, BR; Maia, AC; Rocha, AJ; Tilbery, CP | 1 |
| Cadavid, D; Cheriyan, J; Cook, SD; Kim, S; Wolansky, LJ | 1 |
| A'teriitéhau, C; Arnaud, FX; Baccialone, J; Berets, O; Dutasta, F; Hissene, A; Métivier, D; N'guema, B; Potet, J | 1 |
| Agoropoulou, C; Burtin, P; Calabresi, P; de Vera, A; Francis, G; Hohlfeld, R; Holdbrook, F; Kappos, L; Mueller-Lenke, N; O'Connor, P; Polman, CH; Radue, EW; Selmaj, K; Zhang-Auberson, L | 1 |
| Brown, T; Cohen, B; Daikh, D; Henry, R; Jin, L; Lovera, J; Mohr, DC; Neylan, T; Pelletier, D; Siddique, J | 1 |
| Balk, L; Dijkstra, CD; Heijnen, DA; Killestein, J; Polman, CH; Teunissen, CE; Tewarie, P; Vogt, M; Vrenken, H | 1 |
| Armentero, MT; Bergamaschi, R; Blandini, F; Di Perri, C; Grecchi, S; Lisa, A; Mazzini, G; Romani, A; Scovassi, AI | 1 |
| Dousset, V; Tourdias, T | 1 |
| de Alwis, MP; Gaitán, MI; Nair, G; Reich, DS; Sati, P | 1 |
| Comi, G; Cook, SD; Giovannoni, G; Greenberg, SJ; Hamlett, AC; Rammohan, K; Rieckmann, P; Sørensen, PS; Vermersch, P; Viglietta, V | 1 |
| Levental, M; Moore, FG | 1 |
| Arbel, T; Arnold, DL; Collins, DL; Karimaghaloo, Z | 1 |
| Demir, CF; İnci, MF; Özdemir, HH; Özkan, F | 1 |
| Auer, DP; Holsboer, F; Kümpfel, T; Schumann, EM; Then Bergh, F; Trenkwalder, C | 1 |
| Kastrup, O; Limmroth, V; Stude, P | 1 |
| He, R; Narayana, PA | 1 |
| Barkhof, F; Eikelenboom, MJ; Giovannoni, G; Lazeron, RH; Petzold, A; Polman, CH; Sharief, M; Silber, E; Thompson, EJ; Uitdehaag, BM | 1 |
| Frederiksen, JL; Jensen, CV; Larsson, HB; Sellebjerg, F | 1 |
| Barkhof, F; Comi, G; Durelli, L; Edan, G; Fernández, O; Filippi, M; Francis, G; Hartung, HP; Hommes, OR; Margrie, S; Rocca, M; Rovaris, M; Seeldrayers, P; Sørensen, P; Uitdehaag, BM; Van Waesberghe, JH | 1 |
| Bouvier, S; Cohen, MS; Klutch, R; Mazziotta, JC; Sicotte, NL; Voskuhl, RR | 1 |
| Calabresi, PA; Corboy, JR; Coyle, PK; Filippi, M; Frank, JA; Frohman, EM; Galetta, SL; Goodin, DS; Grossman, RI; Hawker, K; Kachuck, NJ; Levin, MC; Phillips, JT; Racke, MK; Rivera, VM; Stuart, WH | 1 |
| Bronge, L; Gomes, AC; Hillert, J; Jönsson, G; Link, H; Morris, M; Putheti, P; Stawiarz, L | 1 |
| Desai, NK; Runge, VM | 1 |
| Ader, HJ; Barkhof, F; Bergers, E; Bot, JC; Castelijns, JA; de Groot, V; Lycklama à Nijeholt, GJ; Polman, CH | 1 |
| Barkhof, F; Castelijns, JA; Knol, DL; Minneboo, A; Polman, CH; Uitdehaag, BM | 1 |
| Kappos, L; Radue, EW | 1 |
| Gavra, MM; Gouliamos, AD; Sfagos, C; Vlahos, LJ; Voumvourakis, C | 1 |
| Caramia, F; Di Legge, S; Lenzi, GL; Pantano, P; Paolillo, A; Piattella, MC; Pozzilli, C; Russo, P | 1 |
| Smith, D | 1 |
| Dunn, EA; Foster, PJ; Oweida, AJ | 1 |
| Fisher, E; Lee, JC; Ransohoff, RM; Rudick, RA; Simon, J | 1 |
| Achiron, A; Barak, Y; Dolev, M; Faibel, M; Gurevich, M; Kishner, I; Lavie, M; Magalashvili, D; Raz, H; Sarova-Pinhas, I; Stern, Y | 1 |
| Acar, G; Cakmakci, H; Idiman, E; Idiman, F; Ozakbas, S | 1 |
| Dalton, CM; Fernando, K; Miller, DH; Miszkiel, KA; Plant, GT; Swanton, JK; Thompson, AJ | 1 |
| Bakshi, R; Bermel, RA; Fisher, E; Munschauer, FE; Puli, SR; Rudick, RA; Weinstock-Guttman, B | 1 |
| Bellacosa, A; Di Monte, E; Fuiani, A; Giaquinto, P; Livrea, P; Paolicelli, D; Simone, IL; Tortorella, C; Trojano, M | 1 |
| Barkhof, F; Daumer, M; Fazekas, F; Filippi, M; Frank, JA; Held, U; Kappos, L; Li, D; Menzler, S; Miller, DH; Petkau, J; Simon, JH; Wolinsky, J | 1 |
| Bakshi, R; Napoli, SQ | 1 |
| Li, DK; Traboulsee, AL | 1 |
| Frederiksen, JL; Hanson, LG; Knudsen, S; Mathiesen, HK; Nielsen, K; Paulson, OB; Rostrup, E | 1 |
| Michałowska-Wender, G; Wender, M | 1 |
| Agostino, S; Cadoni, G; Cianfoni, A; Colosimo, C; Galli, J; Scipione, S; Tartaglione, T | 1 |
| Basak, M; Erturk, SM; Seleker, F; Uysal, E; Yildirim, H | 1 |
| Banwell, B; Jeffery, D; Ness, JM; Schwid, S; Shroff, M; Weinstock-Guttman, B | 1 |
| Barkhof, F; Bauer, L; Dahms, S; de Vos, M; Edan, G; Freedman, MS; Hartung, HP; Kappos, L; Lasri, F; Miller, DH; Montalbán, X; Pohl, C; Polman, CH; Poppe, P; Radue, EW; Sandbrink, R; Wagner, K | 1 |
| Alvarez-Cermeño, JC; Espiño, M; García-Barragán, N; Gómez-Rial, J; González-Porqué, P; Martínez-San Millán, J; Sádaba, MC; Villar, LM | 1 |
| Lalwani, AK; Mallur, PS | 1 |
| Bensa, C; Brassat, D; Brochet, B; Clavelou, P; De Seze, J; Debouverie, M; Labauge, P; Lebrun, C; Roullet, E; Wiertlievski, S | 1 |
| Arnold, DL; Atkins, HL; Chen, JT; Collins, DL; Freedman, MS | 1 |
| Chowdhury, SA; Lin, J; Sadiq, SA | 1 |
| Barkhof, F; Harzheim, M; Hojati, F; Lutterbey, GG; Schild, HH; Schmidt, S; Simon, B; Wattjes, MP | 1 |
| Brunnschweiler, H; Hagberg, G; Kappos, L; Mader, I; Radue, EW; Roser, W; Seelig, J | 1 |
| Bastianello, S; Buttinelli, C; Millefiorini, E; Pisani, A; Pozzilli, C; Salvetti, M | 1 |
| Fetzer, U; Kornhuber, HH; Krapf, H; Laufen, H; Mauch, E | 1 |
| Baratti, C; Campi, A; Comi, G; Filippi, M; Martinelli, V; Rovaris, M; Scotti, G | 1 |
| Cohen, JA; Gonzalez-Scarano, F; Grossman, RI; Hiehle, JF; Ramer, KN | 1 |
| Clayton, D; Compston, A; Hale, G; Miller, D; Moreau, T; Moseley, I; Scolding, N; Thorpe, J; Waldmann, H; Wing, M | 1 |
| Bardini, JA; Cook, SD; Lee, HJ; Sheffet, A; Wolansky, LJ; Zimmer, AE | 1 |
| Barkhof, F; Miller, DH; Nauta, JJ | 1 |
| Barkhof, F; Frequin, ST; Hommes, OR; Polman, CH; Tas, MW; Valk, J; van Walderveen, MA | 1 |
| Grant, EA; Karlik, SJ; Lee, D; Noseworthy, JH | 1 |
| Minderhoud, JM; s-Gravenmade, EJ; Sinnige, LG | 1 |
| Algra, PR; Barkhof, F; Hommes, OR; Tas, MW; Valk, J | 1 |
| Albert, PS; Armstrong, M; Frank, JA; Maloni, H; Martin, R; McFarland, HF; McFarlin, DE; Smith, ME; Stone, LA | 1 |
| Barbosa, S; Birch, MK; Blumhardt, LD; Harding, SP; O'Brien, C | 1 |
| Gawne-Cain, M; Hodgson, T; Lai, M; MacManus, D; McDonald, WI; Miller, DH; Thompson, AJ; Webb, S | 1 |
| Bressi, S; Campi, A; Colombo, B; Comi, G; Filippi, M; Kandziora, C; Martinelli, V; Scotti, G; Spuler, S; Voltz, R; Yousry, T | 1 |
| Kenndall, BE; Kidd, D; MacManus, DG; McDonald, WI; Miller, DH; Moseley, IF; Thompson, AJ; Thorpe, JW | 1 |
| Bolay, H; Karabudak, R; Onol, B; Saribaş, O; Selekler, K; Tacal, T | 1 |
| Fassbender, K; Hennerici, M; Kühnen, J; Mössner, R; Schwartz, A | 1 |
| Argentino, C; Di Biasi, C; Gasperini, C; Gualdi, GF; Iannilli, M; Koudriavtseva, T; Pozzilli, C; Trasimeni, G | 1 |
| Barnes, D; du Boulay, GH; McDonald, WI; Miller, DH; Rovaris, M; Thompson, AJ; Thorpe, JW; Woodrofe, N | 1 |
| De Salvia, R; Defazio, G; Livrea, P; Ricchiuti, F; Trojano, M | 1 |
| Campi, A; Colombo, B; Comi, G; Filippi, M; Martinelli, V; Scotti, G | 1 |
| Li, DK; Paty, DW | 1 |
| Gantz, BJ; Weber, PC; Zbar, RI | 1 |
| Altenhofen, B; Baudewig, J; Felgenhauer, K; Rieckmann, P; Riegel, A | 1 |
| Bastianello, S; Bozzao, A; Fiorelli, M; Galgani, S; Gasperini, C; Koudriavtseva, T; Paolillo, A; Pisani, A; Pozzilli, C; Thompson, AJ | 1 |
| Bastianello, S; Bozzao, L; Colleluori, A; Fieschi, C; Galgani, S; Gasperini, C; Horsfield, MA; Koudriavtseva, T; Millefiorini, E; Pozzilli, C; Thompson, AJ | 1 |
| Barker, GJ; Davie, CA; Gass, A; Lai, HM; McDonald, WI; Miller, DH; Thompson, AJ; Tofts, PS; Webb, S | 1 |
| Chamoun, V; Feldmann, M; Giovannoni, G; Kidd, D; Lai, M; Miller, DH; Thompson, AJ; Thompson, EJ; Thorpe, J | 1 |
| Comi, G; Fesl, G; Filippi, M; Rocca, MA; Voltz, R; Yousry, T | 1 |
| Barker, GJ; Good, CD; MacManus, DG; McDonald, WI; Miller, DH; Moseley, IF; Silver, NC; Thompson, AJ | 1 |
| Adèr, HJ; Barkhof, F; Castelijns, JA; Kappos, L; Lycklama à Nijeholt, GJ; Miller, DH; Polman, CH; Radue, EW; Roser, W; Silver, N; Uitdehaag, BM; van Waesberghe, JH; Yousry, T | 1 |
| Goodkin, DE | 1 |
| Caillé, JM; Carlier, P; Degreze, P; Dousset, V; Hatier, F; Huot, P | 1 |
| Barkhof, F; Bressi, S; Filippi, M; Miller, DH; Yousry, TA | 1 |
| Adèr, HJ; Barkhof, F; Campi, A; Comi, G; Filippi, M; Losseff, N; Miller, DH; Polman, CH; Scheltens, P; Valk, J | 1 |
| Barkhof, F; Polman, CH; Uitdehaag, BM; van Waesberghe, JH | 1 |
| Adèr, HJ; Barkhof, F; Filippi, M; Lycklama à Nijeholt, G; Miller, DH; Molyneux, P; Radue, EW; Rovaris, M; Tubridy, N; van Waesberghe, JH; Yousry, TA | 1 |
| Fassbender, K; Hennerici, M; Kischka, U; Kühnen, J; Mössner, R; Schmidt, R; Schwartz, A | 1 |
| Doyle, TJ; Lai, D; Narayana, PA; Wolinsky, JS | 1 |
| Alam, JJ; Bartoszak, DM; Bourdette, DN; Braiman, J; Brownscheidle, CM; Campion, M; Choi, K; Cookfair, DL; Fischer, JS; Goodkin, DE; Granger, CV; Herndon, RM; Jacobs, LD; Lajaunie, M; Martens-Davidson, AL; Meyer, M; Richert, JR; Rudick, RA; Salazar, AM; Scherzinger, AL; Sheeder, J; Simon, JH; Simonian, N; Wende, K; Whitham, RH | 1 |
| Barkhof, F; Filippi, M; Gasperini, C; Lai, HM; Miller, DH; Molyneux, PD; Moseley, IF; Rocca, MA; Truyen, L; Yousry, TA | 1 |
| Bruzzi, P; Capello, E; Ferrari, A; Inglese, M; Levrero, F; Mancardi, GL; Melani, E; Ottonello, C; Parodi, RC; Sardanelli, F; Sormani, MP; Uccelli, A | 1 |
| Blinkenberg, M; Jensen, CV; Kirsmeier, H; Larsen, VA; Lee, ML; Ravnborg, M; Schreiber, K; Sorensen, PS; Wanscher, B | 1 |
| Colombo, B; Comi, G; Filippi, M; Horsfield, MA; Minicucci, L; Rizzo, G; Rocca, MA; Rovaris, M | 1 |
| Frank, JA; Miller, DH | 1 |
| Buttinelli, C; Gasperini, C; Laurenti, F; Pozzilli, C; Ristori, G; Salvetti, M; Stacchini, P | 1 |
| Comi, G; Filippi, M; Horsfield, MA; Rocca, MA | 1 |
| Berry, I; Clanet, M | 1 |
| Barker, GJ; Lai, M; McDonald, WI; Miller, DH; Silver, NC; Symms, MR | 1 |
| Bastianello, S; Capra, R; Comi, G; Filippi, M; Gasperini, C; Mastronardo, G; Rocca, MA; Rovaris, M | 1 |
| Lee, MA; Matthews, PM; Palace, J; Smith, S | 1 |
| Coles, A; Compston, DA; Gawne Cain, M; Miller, DH; O'Riordan, JI; Tofts, P; Wang, L | 1 |
| Bagnato, F; Bastianello, S; Ciccarelli, O; Fiorelli, M; Frontoni, M; Galgani, S; Gasperini, C; Koudriavtseva, T; Pozzilli, C | 1 |
| Abundo, M; Bacchetti, P; Gee, L; Goodkin, DE; Majumdar, S; Nelson, S; Rooney, WD; Sloan, R; Vermathen, M; Waubant, E; Weiner, MW | 1 |
| Arnason, BG | 1 |
| Barkhof, F; Castelijns, JA; Lycklama à Nijeholt, GJ; Polman, C; Truyen, L; van Oosten, BW; van Waesberghe, JH; van Walderveen, MA | 1 |
| Arese, M; Bargnani, C; Bussolino, F; Callea, L; Orlandini, A; Priori, A | 1 |
| Saida, T | 1 |
| Arnold, DL; Filippi, M; Lee, MA; Matthews, PM; Miller, DH; Minicucci, L; Narayanan, S; Palace, J; Silver, N; Smith, S | 1 |
| Barkhof, F; Filippi, M; Gasperini, C; Guttmann, CR; Kappos, L; Miller, D; Moeri, D; Radue, EW; Schoetzau, A; Schweikert, K; Weiner, HL | 1 |
| Barker, G; Lai, M; McDonald, I; Miller, D; Silver, N; Symms, M | 1 |
| Bastianello, S; Capra, R; Comi, G; Filippi, M; Rovaris, M; Yousry, TA | 1 |
| Barkhof, F | 1 |
| Andersson, PB; Bacchetti, P; Gee, L; Goodkin, DE; Miller, K; Sloan, R; Stabler, G; Stewart, T; Waubant, E | 1 |
| Avolio, C; Defazio, G; Giuliani, F; Liguori, M; Liuzzi, GM; Livrea, P; Paolicelli, D; Riccio, P; Ruggieri, M; Santacroce, MP; Trojano, M | 1 |
| Barkhof, F; Bastianello, S; Filippi, M; Gasperini, C; Miller, DH; Rovaris, M; Sormani, MP; Tubridy, N; Viti, B; Yousry, TA | 1 |
| Arcuri, T; Losacco, C; Parodi, RC; Renzetti, P; Rosso, E; Sardanelli, F | 1 |
| Chambron, J; Mauss, Y; Namer, IJ; Yu, O; Zollner, G | 1 |
| Barkhof, F; van Walderveen, M | 1 |
| Miller, DH; Molyneux, PD; Moseley, IF; Tubridy, N | 1 |
| Bastianello, S | 1 |
| Auer, DP; Gössl, C; Kümpfel, T; Schumann, EM; Trenkwalder, C | 1 |
| Bastianello, S; Gasperini, C; Giugni, E; Giuliani, S; Mainero, C; Millefiorini, E; Paolillo, A; Pozzilli, C; Tomassini, V | 1 |
| Bilecen, D; Haselhorst, R; Kappos, L; Möri, D; Radü, EW; Scheffler, K; Seelig, J | 1 |
| Davies, MB; Fryer, AA; Haq, N; Hawkins, CP; Mann, CL; Strange, RC; Weatherby, SJ | 1 |
| Jeffery, DR | 1 |
| Bashir, K; Whitaker, JN | 1 |
| Filippi, M | 1 |
| Giovannoni, G; Good, CD; Miller, DH; Silver, NC; Thompson, EJ | 1 |
| Frohman, EM; Hawker, K; Racke, MK | 1 |
| Filippi, M; Rovaris, M | 1 |
| Beguin, C; Carton, H; D'Hooghe, MB; Dooms, G; Lissoir, F; Sindic, CJ; van de Wyngaert, FA | 1 |
| Markovic-Plese, S; McFarland, HF | 1 |
| Beck, RW; Chandler, DL; Cole, SR; Cooper, JA; Jacobs, LD; Kinkel, RP; Murray, TJ; Rice, G; Rose, JW; Sandrock, AW; Selhorst, JB; Simon, JH | 1 |
| Einig, M; Ernst, JP; Higer, HP; Mauz, M | 1 |
| Barkhof, F; Frequin, ST; Hommes, OR; Nauta, JJ; Scheltens, P; Tas, MW; Valk, J | 1 |
| Barkhof, F; Frequin, ST; Hommes, OR; Lamers, KJ | 1 |
| Ebers, GC; Hewitt, L; Hopkins, M; Karlik, SJ; Lee, DH; Noseworthy, JH; Rice, GP; Vandervoort, MK; Wiebe, S; Wong, CJ | 1 |
| Albert, PS; Frank, JA; Harris, JO; Maloni, H; Martin, R; McFarland, HF; McFarlin, DE; Patronas, N; Smith, ME | 1 |
| Panitch, HS | 1 |
| Algra, PR; Barkhof, F; Heijboer, RJ | 1 |
| Frank, JA; Harris, JO; McFarland, HF; McFarlin, DE; Patronas, N | 1 |
| Maeder, P; Meuli, RA; Uské, A | 1 |
| Kermode, AG; Tofts, PS | 1 |
| Barnes, D; McDonald, WI; Munro, PM; Prineas, JW; Youl, BD | 1 |
| Frederiksen, JL; Henriksen, O; Jensen, M; Larsson, HB; Paulson, OB; Stubgaard, M | 1 |
| du Boulay, EP; Kendall, BE; Kermode, AG; Kingsley, DP; MacManus, DG; McDonald, WI; Moseley, IF; Rudge, P; Thompson, AJ; Tofts, PS | 1 |
| Bastianello, S; Bernardi, S; Bozzao, L; Buttinelli, C; Fantozzi, LM; Fieschi, C; Pozzilli, C | 1 |
| Atlas, SW; Galetta, S; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 2 |
| Appel, C; Gowin, W; Mariss, G; Weihe, W | 1 |
36 review(s) available for gadolinium and Multiple Sclerosis
| Article | Year |
|---|---|
Opportunities for Molecular Imaging in Multiple Sclerosis Management: Linking Probe to Treatment.
Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Molecular Imaging; Multiple Sclerosis | 2022 |
Ocrelizumab for multiple sclerosis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Gadolinium; Humans; Interferon beta-1a; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Recurrence | 2022 |
Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE study.
Topics: Adult; Gadolinium; Humans; Immunologic Factors; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Patient Reported Outcome Measures; Quality of Life; Recurrence | 2022 |
New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions.
Topics: Brain; Consensus; Contrast Media; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis | 2020 |
Recent advances in development of nanomedicines for multiple sclerosis diagnosis.
Topics: Contrast Media; Ferric Compounds; Gadolinium; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Multiple Sclerosis; Myelin Sheath; Nanomedicine; Neurodegenerative Diseases; Neurology; Precision Medicine; Silicon Dioxide | 2021 |
Update on brain MRI for the diagnosis and follow-up of MS patients.
Topics: Brain; Contrast Media; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Practice Guidelines as Topic; Registries; Treatment Outcome | 2021 |
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
Topics: Adolescent; Adult; Aged; Child; Consensus; Contrast Media; Disease Progression; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Physiologic; Multiple Sclerosis; Pediatrics; Pregnancy; Prognosis; Reproducibility of Results; Treatment Outcome; Young Adult | 2021 |
A proposal: How to study pro-myelinating proteins in MS.
Topics: Animals; Contrast Media; Gadolinium; Humans; Multiple Sclerosis; Myelin Sheath; Oligodendroglia | 2022 |
The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis.
Topics: Anisotropy; Brain; Contrast Media; Diffusion Tensor Imaging; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2017 |
Gadolinium and Multiple Sclerosis: Vessels, Barriers of the Brain, and Glymphatics.
Topics: Blood-Brain Barrier; Brain; Contrast Media; Gadolinium; Glymphatic System; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis | 2018 |
Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Radiography; Randomized Controlled Trials as Topic | 2015 |
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Topics: Brain; Contrast Media; Demyelinating Diseases; Ferric Compounds; Gadolinium; Humans; Inflammation; Magnetic Resonance Imaging; Multiple Sclerosis; Nanoparticles; Plaque, Amyloid | 2015 |
Effect of interferon-β1α therapy on multiple sclerosis based on gadolinium-enhancing or active T2 magnetic resonance imaging outcomes: a meta-analysis.
Topics: Female; Follow-Up Studies; Gadolinium; Humans; Immunologic Factors; Interferon-beta; Magnetic Resonance Imaging; Male; Multiple Sclerosis | 2016 |
Incidental demyelinating inflammatory lesions in asymptomatic patients: a Brazilian cohort with radiologically isolated syndrome and a critical review of current literature.
Topics: Adolescent; Adult; Age Distribution; Brazil; Disease Progression; Female; Follow-Up Studies; Gadolinium; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination; Radiography; Retrospective Studies; Sex Distribution; Sex Factors; Spinal Cord; Spinal Cord Injuries; Syndrome; Young Adult | 2012 |
Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Gadolinium; Humans; Image Enhancement; Inflammation; Magnetic Resonance Imaging; Multiple Sclerosis; Positron-Emission Tomography | 2013 |
Contrast use at low field: a review.
Topics: Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Joint Diseases; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds | 2003 |
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials.
Topics: Adult; Age of Onset; Brain; Causality; Diagnosis, Differential; Disability Evaluation; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Multivariate Analysis; Nerve Fibers, Myelinated; Odds Ratio; Patient Selection; Predictive Value of Tests; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Treatment Outcome | 2005 |
Magnetic resonance imaging in multiple sclerosis.
Topics: Atrophy; Central Nervous System; Diffusion Magnetic Resonance Imaging; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Predictive Value of Tests | 2005 |
The role of MRI in the diagnosis of multiple sclerosis.
Topics: Central Nervous System; Diagnosis, Differential; Diagnostic Errors; Diffusion Magnetic Resonance Imaging; Disease Progression; Early Diagnosis; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Nerve Fibers, Myelinated | 2006 |
[Magnetic resonance images and spectroscopy in multiple sclerosis].
Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis | 1993 |
Interferon beta treatment for multiple sclerosis: persisting questions.
Topics: Adjuvants, Immunologic; Antibody Formation; Gadolinium; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Multiple Sclerosis; Recombinant Proteins; Treatment Outcome | 1996 |
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
Topics: False Negative Reactions; False Positive Reactions; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Predictive Value of Tests; Time Factors | 1997 |
Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.
Topics: Adolescent; Adult; Brain; Cohort Studies; Disability Evaluation; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Recurrence; Time Factors | 1998 |
Magnetic resonance imaging techniques to monitor short term evolution of multiple sclerosis and to use in preliminary trials.
Topics: Blood-Brain Barrier; Brain; Clinical Trials as Topic; Disease Progression; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Time Factors | 1998 |
Magnetic resonance imaging in multiple sclerosis.
Topics: Diffusion; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Predictive Value of Tests; Prognosis | 1998 |
Immunologic therapy of multiple sclerosis.
Topics: Adjuvants, Immunologic; Contrast Media; Disease Progression; Gadolinium; Glatiramer Acetate; Humans; Image Enhancement; Immunosuppressive Agents; Immunotherapy; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Peptides; Polymers; Recombinant Proteins; Recurrence | 1999 |
[Magnetic resonance imaging in multiple sclerosis].
Topics: Brain; Clinical Trials as Topic; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Multiple Sclerosis; Reference Standards | 1999 |
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.
Topics: Adolescent; Adult; Blood-Brain Barrier; Brain; Clinical Trials as Topic; Contrast Media; Disabled Persons; Disease Progression; Female; Forecasting; Gadolinium; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multicenter Studies as Topic; Multiple Sclerosis; Odds Ratio; Predictive Value of Tests; Prognosis; Recurrence; Regression Analysis; Risk Factors | 1999 |
MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS).
Topics: Contrast Media; Cross-Sectional Studies; Disability Evaluation; Disease Progression; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Severity of Illness Index | 1999 |
Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
Topics: Blood-Brain Barrier; Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis | 1999 |
Conventional magnetic resonance sequences in multiple sclerosis.
Topics: Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 1999 |
Relationship between disease activity and dose-response relationships with beta interferon therapies in the treatment of multiple sclerosis.
Topics: Adjuvants, Immunologic; Dose-Response Relationship, Drug; Gadolinium; Humans; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Radioisotopes; Treatment Outcome | 2000 |
Enhanced magnetic resonance imaging in multiple sclerosis.
Topics: Clinical Trials as Topic; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2000 |
Contrast enhancement and the acute lesion in multiple sclerosis.
Topics: Brain; Contrast Media; Disease Progression; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Neurologic Examination; Prognosis | 2000 |
Immunopathogenesis of the multiple sclerosis lesion.
Topics: Antigen Presentation; Apoptosis; Astrocytes; Autoantigens; Autoimmune Diseases; Axons; Blood-Brain Barrier; Brain; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemotaxis, Leukocyte; Contrast Media; Cytokines; Gadolinium; Gliosis; Humans; Lymphocyte Activation; Macrophage Activation; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Myelin Proteins; Oligodendroglia | 2001 |
The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.
Topics: Gadolinium; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis | 1992 |
45 trial(s) available for gadolinium and Multiple Sclerosis
| Article | Year |
|---|---|
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Crotonates; Double-Blind Method; Gadolinium; Humans; Hydroxybutyrates; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Nitriles; Toluidines | 2022 |
Gadolinium-enhanced brain lesions in multiple sclerosis relapse.
Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Recurrence | 2022 |
MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.
Topics: Acute Disease; Adolescent; Adult; Blood-Brain Barrier; Cerebral Cortex; Female; Gadolinium; Humans; Image Enhancement; Inflammation; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; White Matter; Young Adult | 2017 |
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Topics: Adult; Aged; Brain; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neurons; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2013 |
Transdermal application of myelin peptides in multiple sclerosis treatment.
Topics: Administration, Cutaneous; Adult; Cohort Studies; DNA-Binding Proteins; Double-Blind Method; Drug Therapy, Combination; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Myelin Sheath; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Secondary Prevention; Transcription Factors | 2013 |
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Disability Evaluation; Double-Blind Method; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Recurrence; Treatment Outcome | 2014 |
Fingolimod therapy in early multiple sclerosis: an efficacy analysis of the TRANSFORMS and FREEDOMS studies by time since first symptom.
Topics: Adult; Disease Progression; Female; Fingolimod Hydrochloride; Gadolinium; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Propylene Glycols; Secondary Prevention; Sphingosine; Time Factors; Treatment Outcome | 2014 |
MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.
Topics: Adult; Brain Injuries; Female; Gadolinium; Glatiramer Acetate; Humans; Imaging, Three-Dimensional; Immunologic Factors; Interferon beta-1b; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Reproducibility of Results | 2016 |
Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patients.
Topics: Adult; Aged; Contrast Media; Disability Evaluation; Female; Gadolinium; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Sensitivity and Specificity; Spinal Cord; Young Adult | 2017 |
[Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year].
Topics: Adult; Disease Progression; Female; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis; Retrospective Studies; Secondary Prevention; Treatment Outcome; Young Adult | 2008 |
Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria.
Topics: Adjuvants, Immunologic; Adult; Algorithms; Brain; Disease Progression; Female; Gadolinium; Humans; Injections, Intramuscular; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Multivariate Analysis; Risk Assessment; Risk Factors | 2009 |
Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study.
Topics: Adult; Antibodies; Contrast Media; Drug Tolerance; Female; Gadolinium; Humans; Immunologic Factors; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prospective Studies; Single-Blind Method; Time Factors; Treatment Outcome | 2009 |
A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
Topics: Administration, Oral; Adult; Brain; Disability Evaluation; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gadolinium; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; ROC Curve; Statistics, Nonparametric; Time Factors; Young Adult | 2009 |
Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials.
Topics: Adult; Brain; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Outcome Assessment, Health Care; Protein Kinase Inhibitors; Sirolimus; Statistics, Nonparametric | 2010 |
Long-term results of stem cell transplantation for MS: a single-center experience.
Topics: Adult; Brain; Disease Progression; Disease-Free Survival; Female; Gadolinium; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Radionuclide Imaging; Transplantation Conditioning; Treatment Outcome | 2011 |
Impact of inflammation on brain volume in multiple sclerosis.
Topics: Brain; Disease Progression; Encephalitis; Female; Gadolinium; Glatiramer Acetate; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Peptides; Statistics, Nonparametric; Time Factors | 2012 |
Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
Topics: Administration, Oral; Adolescent; Adult; Brain; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Encephalitis; Female; Fingolimod Hydrochloride; Gadolinium; Humans; Immunosuppressive Agents; International Cooperation; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Outcome Assessment, Health Care; Propylene Glycols; Sphingosine; Time Factors; Young Adult | 2012 |
A randomized trial of stress management for the prevention of new brain lesions in MS.
Topics: Adult; Brain Injuries; Chi-Square Distribution; Cognitive Behavioral Therapy; Disability Evaluation; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Single-Blind Method; Stress, Physiological; Time Factors; Treatment Outcome | 2012 |
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Topics: Analysis of Variance; Brain; Cladribine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Secondary Prevention; Severity of Illness Index; Tablets; Treatment Outcome | 2013 |
Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.
Topics: Adult; Autoantibodies; Biomarkers; Brain; Brain Diseases; Disease Progression; Female; Gadolinium; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurofilament Proteins; Predictive Value of Tests | 2003 |
Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis.
Topics: Adult; Anti-Inflammatory Agents; Blood-Brain Barrier; Female; Gadolinium; Humans; Immunoglobulin A; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Predictive Value of Tests; Treatment Outcome | 2003 |
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Brain; Female; Follow-Up Studies; Gadolinium; Humans; Immunoglobulin G; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Randomized Controlled Trials as Topic; Reproducibility of Results | 2003 |
Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
Topics: Adolescent; Adult; Brain Stem; Child; Disability Evaluation; Disease Progression; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Prognosis; Proportional Hazards Models | 2004 |
Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Subtraction Technique | 2004 |
Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
Topics: Adult; Brain; Cyclophosphamide; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Gadolinium; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Salvage Therapy; Single-Blind Method; Treatment Outcome | 2004 |
Defining interferon beta response status in multiple sclerosis patients.
Topics: Adult; Brain Infarction; Disability Evaluation; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Reproducibility of Results; Secondary Prevention; Severity of Illness Index; Time Factors; Treatment Outcome | 2004 |
Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Brain; Demyelinating Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Gadolinium; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Odds Ratio; Time Factors; Treatment Outcome | 2004 |
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Topics: Adolescent; Adult; Contrast Media; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Injections, Subcutaneous; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 2007 |
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions.
Topics: Adult; Central Nervous System; Disease Progression; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Nerve Fibers, Myelinated; Nerve Regeneration; Recovery of Function; Severity of Illness Index; Stem Cell Transplantation; Time Factors | 2008 |
Triple-dose versus single-dose gadoteridol in multiple sclerosis patients.
Topics: Brain; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds | 1994 |
Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Time Factors | 1996 |
High-dose contrast-enhanced MRI in multiple sclerosis.
Topics: Adult; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1996 |
Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.
Topics: Adult; Brain; Cell Adhesion Molecules; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prospective Studies | 1997 |
Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.
Topics: Adult; Brain; Chi-Square Distribution; Cross-Over Studies; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Odds Ratio; Predictive Value of Tests; Recurrence; Regression Analysis | 1997 |
Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis.
Topics: Brain; Chi-Square Distribution; False Positive Reactions; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Observer Variation; Reproducibility of Results | 1997 |
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.
Topics: Brain; Double-Blind Method; Gadolinium; Humans; Injections, Intramuscular; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Recurrence; Treatment Outcome | 1998 |
Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis.
Topics: Gadolinium; Glatiramer Acetate; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis; Peptides; Recurrence | 1998 |
Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis.
Topics: Adolescent; Adult; Cross-Over Studies; Disease Progression; Double-Blind Method; Evoked Potentials; Female; Gadolinium; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Recurrence | 1998 |
Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium.
Topics: Adult; Disability Evaluation; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Injections; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Recurrence; Remission Induction | 1998 |
Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosis.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Interferon-beta; Linear Models; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Statistics, Nonparametric; Treatment Outcome | 1998 |
Serial gadolinium-enhanced and magnetization transfer imaging to investigate the relationship between the duration of blood-brain barrier disruption and extent of demyelination in new multiple sclerosis lesions.
Topics: Adult; Blood-Brain Barrier; Demyelinating Diseases; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis; Time Factors | 1999 |
Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI.
Topics: Adolescent; Adult; Demyelinating Diseases; Diagnosis, Differential; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Somatosensory; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Myelitis; Prospective Studies | 2000 |
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
Topics: Adult; Alopecia; Contrast Media; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylene Blue; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Nausea; Patient Dropouts; Phlebitis; Pulmonary Embolism; Pyrrolidines; Recurrence; Severity of Illness Index; Treatment Outcome; Vomiting | 2001 |
Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses.
Topics: Adjuvants, Immunologic; Adult; Age of Onset; Brain Stem; Cerebellum; Female; Gadolinium; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Optic Neuritis; Spinal Cord; Treatment Outcome | 2002 |
Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis.
Topics: Brain; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Spinal Cord | 1992 |
228 other study(ies) available for gadolinium and Multiple Sclerosis
| Article | Year |
|---|---|
Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
Topics: Adult; Deep Learning; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neural Networks, Computer | 2021 |
Gadolinium enhancement of cranial nerves: Implications for interstitial fluid drainage from brainstem into cranial nerves in humans.
Topics: Adult; Blood-Brain Barrier; Brain Stem; Cranial Nerves; Extracellular Fluid; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis | 2021 |
Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients.
Topics: Case-Control Studies; Cerebellar Nuclei; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2022 |
Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.
Topics: Brain; Contrast Media; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2022 |
Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Point-The Role of Leptomeningeal Enhancement.
Topics: Contrast Media; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2022 |
Impact of comorbid post traumatic stress disorder on multiple sclerosis in military veterans: A population-based cohort study.
Topics: Cohort Studies; Disease Progression; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Stress Disorders, Post-Traumatic; Veterans | 2022 |
Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
Topics: Brain; Contrast Media; Gadolinium; Humans; Inflammation; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; White Matter | 2022 |
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Topics: Atrophy; Brain; Central Nervous System Diseases; Contrast Media; Gadolinium; Gray Matter; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurodegenerative Diseases; Prospective Studies; Reproducibility of Results | 2022 |
Economic impact of selective use of contrast for routine follow-up MRI of patients with multiple sclerosis.
Topics: Aged; Contrast Media; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Medicare; Multiple Sclerosis; United States | 2022 |
Evolution of acute "black hole" lesions in patients with relapsing-remitting multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; White Matter | 2023 |
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.
Topics: Biomarkers; Demyelinating Diseases; Gadolinium; Glial Fibrillary Acidic Protein; Humans; Intermediate Filaments; Matrix Metalloproteinase 7; Minocycline; Multiple Sclerosis; Neurofilament Proteins | 2022 |
Impact of post-contrast MRI in the definition of active multiple sclerosis.
Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Retrospective Studies | 2022 |
Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30).
Topics: Adult; Female; Gadolinium; Humans; Immunologic Factors; Infant; Infant, Newborn; Iron; Multiple Sclerosis; Natalizumab; Observational Studies as Topic; Pregnancy; Retrospective Studies | 2022 |
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic.
Topics: COVID-19; Gadolinium; Humans; Immunologic Factors; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Pandemics; Recurrence | 2022 |
Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy.
Topics: Atrophy; Central Nervous System Diseases; Choroid Plexus; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurodegenerative Diseases | 2022 |
Editorial Comment: Gadolinium-Based Contrast Agent and the Central Vein Sign.
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2023 |
Letter to the editor: Should we stop using post-contrast sequences in the follow-up MRI of patients with multiple sclerosis?
Topics: Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2022 |
The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients.
Topics: Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2022 |
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents.
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2022 |
Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis.
Topics: Adult; Contrast Media; Cross-Sectional Studies; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Processing Speed; Retrospective Studies | 2023 |
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study.
Topics: Brain; Gadolinium; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Retrospective Studies; Spinal Cord | 2023 |
[A case of multiple sclerosis with a tumefactive lesion during long-term treatment with fingolimod, leading to decompressive craniotomy].
Topics: Contrast Media; Decompressive Craniectomy; Fingolimod Hydrochloride; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 2023 |
MRI detection of brain gadolinium retention in multiple sclerosis: Magnetization transfer vs. T1-weighted imaging.
Topics: Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Retrospective Studies | 2023 |
Lesion location across diagnostic regions in multiple sclerosis.
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neuroimaging | 2023 |
Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis: Association With Linear Versus Macrocyclic Gadolinium-Based Contrast Agents Administration.
Topics: Adult; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies; Scalp | 2023 |
MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis.
Topics: Cerebellar Nuclei; Cognition; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2023 |
Relevance of dedicated multiple sclerosis serum biomarkers in predicting contrast enhancement with gadolinium: Results from the REDUCE-GAD trial.
Topics: Biological Specimen Banks; Biomarkers; Contrast Media; Gadolinium; Glial Fibrillary Acidic Protein; Humans; Multiple Sclerosis; Neurofilament Proteins; Prospective Studies | 2023 |
Treatments of paediatric multiple sclerosis: Efficacy and tolerance in a longitudinal follow-up study.
Topics: Adolescent; Child; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Interferon beta-1a; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Retrospective Studies | 2023 |
Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis.
Topics: Algorithms; Blood Proteins; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2023 |
A prospective observational longitudinal study with a two-year follow-up of multiple sclerosis patients on Cladribine.
Topics: Adult; Cladribine; Contrast Media; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies | 2023 |
Pseudocystic inflammatory demyelinating lesions in multiple sclerosis: A clinical, radiological, and pathological description.
Topics: Biopsy; Contrast Media; Gadolinium; Humans; Multiple Sclerosis; Retrospective Studies | 2023 |
A multicenter study of radiologically isolated syndrome in children and adolescents: Can we predict the course?
Topics: Adolescent; Autoimmune Diseases of the Nervous System; Child; Contrast Media; Demyelinating Diseases; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Oligoclonal Bands; Retrospective Studies | 2023 |
Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?
Topics: Adult; Brain; Cerebral Cortex; Contrast Media; Disease Progression; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; White Matter | 2019 |
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets.
Topics: Contrast Media; Disability Evaluation; Gadolinium; Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Outcome Assessment, Health Care; Walking | 2020 |
T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple Sclerosis.
Topics: Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2021 |
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent.
Topics: Aged; Contrast Media; Cross-Sectional Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Retrospective Studies | 2020 |
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Retrospective Studies | 2020 |
Clinically isolated syndrome and multiple sclerosis in children: a single center study.
Topics: Aged; Brain; Child; Contrast Media; Disease Progression; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Retrospective Studies | 2020 |
Deep learning segmentation of gadolinium-enhancing lesions in multiple sclerosis.
Topics: Deep Learning; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neural Networks, Computer | 2021 |
Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis.
Topics: Adult; Biological Assay; Biomarkers; Brain; Female; Gadolinium; Humans; Image Enhancement; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Neurofilament Proteins; Optic Nerve; Recurrence; Severity of Illness Index; Spinal Cord; Time Factors | 2020 |
Gadolinium should always be used to assess disease activity in MS - No.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2020 |
Gadolinium should always be used to assess disease activity in MS - Yes.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2020 |
Do you believe in Gad?
Topics: Brain; Contrast Media; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis | 2020 |
The role of contrast-enhanced and non-contrast-enhanced MRI in the follow-up of multiple sclerosis.
Topics: Adult; Contrast Media; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Predictive Value of Tests; Retrospective Studies | 2021 |
Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
Topics: Adult; Aged; Aged, 80 and over; Female; Gadolinium; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; Multiple Sclerosis; Young Adult | 2020 |
In Vivo Proton Exchange Rate (k
Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Protons; Retrospective Studies | 2021 |
Estimation of Multiple Sclerosis lesion age on magnetic resonance imaging.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Machine Learning; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Reproducibility of Results; Time Factors | 2021 |
Limited Utility of Gadolinium Contrast Administration in Routine Multiple Sclerosis Surveillance.
Topics: Administration, Intravenous; Adult; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mass Screening; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2021 |
ENT-MS-12 questionnaire: A novel tool to investigate otolaryngology symptoms in patients with relapsing-remitting multiple sclerosis. Results from a pilot study.
Topics: Contrast Media; Disability Evaluation; Disease Progression; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Otolaryngology; Pilot Projects; Surveys and Questionnaires | 2021 |
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?
Topics: Biomarkers; Contrast Media; Gadolinium; Humans; Inflammation; Lymphocytes; Multiple Sclerosis; Neurofilament Proteins; Neutrophils; Retrospective Studies | 2021 |
Quantitative susceptibility-weighted imaging in predicting disease activity in multiple sclerosis.
Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; White Matter | 2021 |
Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD score.
Topics: Contrast Media; Disability Evaluation; Gadolinium; Glatiramer Acetate; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2021 |
Multiple sclerosis: prevalence of the 'central vein' sign in white matter lesions on gadolinium-enhanced susceptibility-weighted images.
Topics: Adult; Aged; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prevalence; Prospective Studies; White Matter; Young Adult | 2021 |
Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.
Topics: Adult; Blood-Brain Barrier; Brain; Brain Mapping; Contrast Media; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 2021 |
[The pharmacological economic analysis of application of magnetic resonance contrast mediums containing gadolinium in case of multiple sclerosis].
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis | 2021 |
Analysis of the Gadolinium retention in the Experimental Autoimmune Encephalomyelitis (EAE) murine model of Multiple Sclerosis.
Topics: Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gadolinium; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Organometallic Compounds | 2021 |
The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK.
Topics: Contrast Media; Gadolinium; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Retrospective Studies; United Kingdom | 2021 |
Tracking the Evolution of Cerebral Gadolinium-Enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline.
Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2017 |
Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis.
Topics: Adult; Aged; Brain; Brain Ischemia; Contrast Media; Female; Gadolinium; Humans; Leukoaraiosis; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Veins; Young Adult | 2017 |
Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis.
Topics: Adult; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Humans; Male; Multiple Sclerosis; Prospective Studies | 2017 |
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.
Topics: Adult; Aging; Cerebellar Nuclei; Cognition; Cohort Studies; Contrast Media; Female; Gadolinium; Globus Pallidus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neuropsychological Tests; Retrospective Studies; Verbal Behavior | 2017 |
Differentiating enhancing multiple sclerosis lesions, glioblastoma, and lymphoma with dynamic texture parameters analysis (DTPA): A feasibility study.
Topics: Brain Neoplasms; Contrast Media; Diagnosis, Differential; Feasibility Studies; Gadolinium; Gadolinium DTPA; Glioblastoma; Humans; Image Enhancement; Lymphoma; Magnetic Resonance Imaging; Multiple Sclerosis | 2017 |
Sodium MRI of T1 High Signal Intensity in the Dentate Nucleus due to Gadolinium Deposition in Multiple Sclerosis.
Topics: Adult; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Pons; Retrospective Studies; Sodium | 2017 |
T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Disease Progression; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 2017 |
Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
Topics: Adult; Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2018 |
USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-up.
Topics: Adult; Brain; Demyelinating Diseases; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monocytes; Multiple Sclerosis | 2018 |
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.
Topics: Adult; Antigens, CD19; B-Lymphocytes; Brain; Cerebrospinal Fluid; Chemokine CXCL13; Female; Flow Cytometry; Gadolinium; Humans; Male; Middle Aged; Multiple Sclerosis; T-Lymphocytes; Young Adult | 2017 |
Evolving diagnostic criteria for multiple sclerosis.
Topics: Biomarkers; Diagnosis, Differential; Electroencephalography; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis; Neurologic Examination | 2018 |
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients.
Topics: Adult; Antibodies, Monoclonal, Humanized; Brain; Cohort Studies; Disability Evaluation; Female; Fingolimod Hydrochloride; Gadolinium; Humans; Immunosuppressive Agents; Italy; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Natalizumab; Time Factors; Treatment Outcome | 2018 |
Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
Topics: Adult; Aged; Contrast Media; Female; Gadolinium; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; Multiple Sclerosis; Neuroimaging; Reproducibility of Results; Sensitivity and Specificity | 2018 |
Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) pati
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2018 |
Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain-a retrospective study in 158 multiple sclerosis
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2018 |
Potential role of lipoic acid as a chelator in prevention and treatment of gadolinium brain retention.
Topics: Animals; Antioxidants; Blood-Brain Barrier; Brain; Chelating Agents; Gadolinium; Humans; Magnetic Resonance Imaging; Metals, Heavy; Multiple Sclerosis; Reproducibility of Results; Thioctic Acid | 2018 |
Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis.
Topics: Adult; Contrast Media; Dimethyl Fumarate; Disease Progression; Drug Substitution; Female; Fingolimod Hydrochloride; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Withholding Treatment | 2018 |
The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis.
Topics: Adult; Contrast Media; Drug Administration Schedule; Female; Fingolimod Hydrochloride; Gadolinium; Humans; Immunologic Factors; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Natalizumab; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2018 |
Gadolinium effect on thalamus and whole brain tissue segmentation.
Topics: Algorithms; Brain; Contrast Media; Gadolinium; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis; Thalamus | 2018 |
Cervical MRI Rating Scale: Innovative Approach to Differentiate between Demyelinating and Disc Lesions.
Topics: Adult; Cervical Vertebrae; Contrast Media; Demyelinating Diseases; Diagnosis, Differential; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Reproducibility of Results; Retrospective Studies; Spinal Cord Diseases; Spondylosis | 2019 |
MRI-guided intracerebral convection-enhanced injection of gliotoxins to induce focal demyelination in swine.
Topics: Animals; Brain; Convection; Demyelinating Diseases; Gadolinium; Gliotoxin; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin Sheath; Nervous System Malformations; Swine; Tissue Distribution | 2018 |
Myelinating Proteins in MS Are Linked to Volumetric Brain MRI Changes.
Topics: Adult; Biomarkers; Brain; Brain-Derived Neurotrophic Factor; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Recurrence | 2019 |
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis.
Topics: Adult; Cytokine TWEAK; Female; Gadolinium; Humans; Inflammation; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Nervous System; Recurrence; Solubility | 2019 |
Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis.
Topics: Adult; Brain; Brain Diseases; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2019 |
Is Gadolinium-based Contrast Material Needed for MRI Follow-up of Multiple Sclerosis?
Topics: Brain; Contrast Media; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2019 |
An Initiative to Reduce Unnecessary Gadolinium-Based Contrast in Multiple Sclerosis Patients.
Topics: Contrast Media; Gadolinium; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis; Prospective Studies; Quality Improvement; Unnecessary Procedures | 2019 |
What is the Relevance of the Systematic Use of Gadolinium During the MRI Follow-Up of Multiple Sclerosis Patients Under Natalizumab?
Topics: Adult; Contrast Media; Female; France; Gadolinium; Humans; Immunologic Factors; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Natalizumab; Retrospective Studies | 2020 |
Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
Topics: Adult; Brain; Contrast Media; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2019 |
Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Abscess; Brain Neoplasms; Child; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Young Adult | 2019 |
Improving acute demyelinating lesion detection: which T1-weighted magnetic resonance acquisition is more sensitive to gadolinium enhancement?
Topics: Adolescent; Adult; Brain; Contrast Media; Demyelinating Diseases; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Sensitivity and Specificity; Young Adult | 2019 |
Imaging new lesions: enhancing our understanding of multiple sclerosis pathogenesis.
Topics: Brain; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Organometallic Compounds | 2013 |
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
Topics: Adult; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds | 2013 |
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Cohort Studies; Disability Evaluation; Female; Gadolinium; Humans; Immunologic Factors; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Natalizumab; Time Factors; Young Adult | 2014 |
Contrast enhanced MR venography with gadofosveset trisodium: evaluation of the intracranial and extracranial venous system.
Topics: Adult; Artifacts; Cerebrovascular Circulation; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity; Veins | 2014 |
Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.
Topics: Adult; Contrast Media; Female; Gadolinium; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2014 |
Adaptive voxel, texture and temporal conditional random fields for detection of Gad-enhancing multiple sclerosis lesions in brain MRI.
Topics: Algorithms; Brain; Contrast Media; Data Interpretation, Statistical; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Multiple Sclerosis; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis.
Topics: Adult; Aged; Brain; Contrast Media; Echo-Planar Imaging; Female; Gadolinium; Humans; Iron; Male; Middle Aged; Multiple Sclerosis | 2014 |
Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learning.
Topics: Adult; Algorithms; Contrast Media; Dextrans; Female; Gadolinium; Humans; Machine Learning; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Multiple Sclerosis; Time Factors | 2014 |
Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Brain; Female; Gadolinium; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Natalizumab; Neuroimaging; Prospective Studies; Recurrence | 2014 |
Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.
Topics: Adolescent; Adult; Brain; Contrast Media; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Reproducibility of Results; Young Adult | 2014 |
Automated identification of brain new lesions in multiple sclerosis using subtraction images.
Topics: Algorithms; Brain; Contrast Media; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2014 |
Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
Topics: Adult; Antibodies, Anti-Idiotypic; Antibodies, Antinuclear; Aquaporin 4; Biopsy; Brain; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Leukoencephalitis, Acute Hemorrhagic; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Severity of Illness Index; Young Adult | 2014 |
High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
Topics: Adult; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Female; Flow Cytometry; Gadolinium; Gene Expression; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Receptors, CCR1; Receptors, CCR5; RNA, Messenger; T-Lymphocytes; Young Adult | 2014 |
Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI.
Topics: Algorithms; Brain; Gadolinium; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis; Radionuclide Imaging | 2015 |
Subclinical MRI disease activity influences cognitive performance in MS patients.
Topics: Adult; Atrophy; Case-Control Studies; Cognition Disorders; Contrast Media; Corpus Callosum; Female; Gadolinium; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organ Size; Prospective Studies | 2015 |
Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring.
Topics: Brain; Canada; Clinical Protocols; Consensus; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Monitoring, Physiologic; Multiple Sclerosis | 2015 |
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis.
Topics: Adolescent; Adult; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Prolactin; White Matter; Young Adult | 2015 |
Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocy
Topics: Cerebellar Nuclei; Contrast Media; Gadolinium; Globus Pallidus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2016 |
Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple Sclerosis.
Topics: Adult; Aged; Atrophy; Cervical Cord; Contrast Media; Disability Evaluation; Female; Gadolinium; Head; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Reproducibility of Results | 2016 |
Characterization of Enhancing MS Lesions by Dynamic Texture Parameter Analysis of Dynamic Susceptibility Perfusion Imaging.
Topics: Adult; Aged; Contrast Media; Disease Susceptibility; Female; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Perfusion Imaging | 2016 |
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
Topics: Adaptation, Physiological; Adaptation, Psychological; Adult; Brain; Brain Mapping; Cohort Studies; Contrast Media; Female; Gadolinium; Humans; Immunologic Factors; Interferon beta-1a; Magnetic Resonance Imaging; Male; Motor Activity; Multiple Sclerosis; Neuronal Plasticity; Neuropsychological Tests; Practice, Psychological; Treatment Outcome; Visual Perception | 2016 |
Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast.
Topics: Adult; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Retrospective Studies; Tissue Distribution | 2016 |
Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Observer Variation; Young Adult | 2017 |
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Phobic Disorders | 2016 |
The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Female; Gadolinium; Humans; Male; Multiple Sclerosis; Retrospective Studies; Sensitivity and Specificity | 2016 |
The distribution of new enhancing lesion counts in multiple sclerosis: further explorations.
Topics: Adolescent; Adult; Brain; Databases, Factual; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Poisson Distribution; Young Adult | 2009 |
Role of MRI in the differentiation of ADEM from MS in children.
Topics: Adolescent; Brain; Child; Cohort Studies; Contrast Media; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Female; Gadolinium; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Multiple Sclerosis | 2009 |
MRI as an outcome in multiple sclerosis clinical trials.
Topics: Adult; Cross-Sectional Studies; Disability Evaluation; Gadolinium; Humans; Image Enhancement; Longitudinal Studies; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic | 2009 |
Evolution of glioblastoma.
Topics: Brain Neoplasms; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis | 2009 |
No shortcuts to outcome in MS clinical trials?
Topics: Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
Topics: Adult; Central Nervous System; Cohort Studies; Contrast Media; Disease Progression; Early Diagnosis; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Predictive Value of Tests; Prognosis; Reproducibility of Results; Time Factors | 2009 |
Seeing injectable MS therapies differently: they are more similar than different.
Topics: Adjuvants, Immunologic; Biomarkers; Central Nervous System; Disease Progression; Gadolinium; Glatiramer Acetate; Humans; Injections; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Outcome Assessment, Health Care; Peptides; Predictive Value of Tests; Randomized Controlled Trials as Topic; Secondary Prevention; Sensitivity and Specificity; Treatment Outcome | 2009 |
Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica.
Topics: Adult; Aquaporin 4; Autoantibodies; Autoantigens; Blood-Brain Barrier; Brain Edema; Contrast Media; Diagnostic Errors; Diffusion Magnetic Resonance Imaging; Encephalomyelitis, Acute Disseminated; Female; Gadolinium; Humans; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Mycoplasma pneumoniae; Myelitis, Transverse; Neuromyelitis Optica; Pneumonia, Mycoplasma; Radiography | 2009 |
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint.
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Computer Simulation; Contrast Media; Cost-Benefit Analysis; Endpoint Determination; Gadolinium; Health Care Costs; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Economic; Multiple Sclerosis; Predictive Value of Tests; Regression Analysis; Research Design; Time Factors; Treatment Outcome | 2010 |
Detection of Gad-enhancing lesions in multiple sclerosis using conditional random fields.
Topics: Algorithms; Brain; Contrast Media; Data Interpretation, Statistical; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.
Topics: Adult; Amyloid beta-Peptides; Cerebral Cortex; Cognition Disorders; Evoked Potentials, Motor; Female; Functional Laterality; Gadolinium; Humans; Long-Term Potentiation; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Muscle, Skeletal; Neuronal Plasticity; Neurons; Neuropsychological Tests; Peptide Fragments; Statistics as Topic; tau Proteins; Time Factors; Transcranial Magnetic Stimulation; Young Adult | 2011 |
Repeated non-enhancing tumefactive lesions in a patient with a neuromyelitis optica spectrum disorder.
Topics: Aphasia, Broca; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Evoked Potentials, Visual; Female; Gadolinium; Humans; Immunoglobulin G; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Recurrence | 2011 |
Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions.
Topics: Adult; Blood-Brain Barrier; Brain; Computer Simulation; Contrast Media; Female; Gadolinium; Humans; Kinetics; Magnetic Resonance Imaging; Models, Statistical; Multiple Sclerosis; Permeability; Time Factors | 2011 |
Detection of active plaques in multiple sclerosis using susceptibility-weighted imaging: comparison with gadolinium-enhanced MR imaging.
Topics: Adolescent; Adult; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity | 2011 |
Automatic detection of gadolinium-enhancing multiple sclerosis lesions in brain MRI using conditional random fields.
Topics: Algorithms; Brain; Contrast Media; Data Interpretation, Statistical; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Gadolinium enhancement in brain magnetic resonance imaging in progressive multifocal leukoencephalopathy after natalizumab monotherapy: is it really atypical?
Topics: Adult; Antibodies, Monoclonal, Humanized; Contrast Media; Gadolinium; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Natalizumab | 2012 |
Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
Topics: Adult; Aged; Autoantibodies; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Myelin Sheath; Severity of Illness Index | 2012 |
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Topics: Adult; Apoptosis; Biomarkers; Case-Control Studies; DNA Breaks, Double-Stranded; Female; Follow-Up Studies; Gadolinium; Histones; Humans; Lymphocytes; Male; Multiple Sclerosis; Oxidative Stress; Phosphorylation; Poly(ADP-ribose) Polymerases; Serine | 2012 |
Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.
Topics: Adult; Cerebral Veins; Contrast Media; Disability Evaluation; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Sex Characteristics | 2013 |
The usefulness of gadolinium-enhanced images on a follow-up magnetic resonance image in suspected multiple sclerosis.
Topics: Adolescent; Adult; Aged; Canada; Contrast Media; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prospective Studies; Young Adult | 2013 |
Hierarchical conditional random fields for detection of gad-enhancing lesions in multiple sclerosis.
Topics: Algorithms; Brain; Computer Simulation; Contrast Media; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Statistical; Multiple Sclerosis; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques?
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Thermometry | 2013 |
Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume.
Topics: Adult; Area Under Curve; Atrophy; Brain; Corticotropin-Releasing Hormone; Dexamethasone; Female; Gadolinium; Humans; Hypothalamo-Hypophyseal System; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Pituitary-Adrenal System; Statistics as Topic | 2002 |
Balo's concentric sclerosis. Evolution of active demyelination demonstrated by serial contrast-enhanced MRI.
Topics: Adult; Diffuse Cerebral Sclerosis of Schilder; Disease Progression; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Recurrence | 2002 |
Automatic delineation of Gd enhancements on magnetic resonance images in multiple sclerosis.
Topics: Anisotropy; Brain; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meninges; Models, Theoretical; Multiple Sclerosis; Radiography | 2002 |
Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla.
Topics: Adolescent; Adult; Brain; Child; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Sensitivity and Specificity | 2003 |
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Topics: Adult; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Prognosis; Research; Sensitivity and Specificity | 2003 |
Decreased levels of CD95 and caspase-8 mRNA in multiple sclerosis patients with gadolinium-enhancing lesions on MRI.
Topics: Adult; Aged; Aged, 80 and over; Caspase 8; Caspase 9; Caspases; fas Receptor; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; RNA, Messenger; Statistics, Nonparametric | 2003 |
Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organ Specificity; Spinal Cord | 2004 |
Vancouver Consortium of MS Centers' Magnetic Resonance Imaging Guidelines.
Topics: Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Practice Guidelines as Topic | 2003 |
The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
Topics: Adolescent; Adult; Atrophy; Brain; Confidence Intervals; Echo-Planar Imaging; Female; Follow-Up Studies; Gadolinium; Humans; Inflammation; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Statistics, Nonparametric; Syndrome | 2004 |
Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide.
Topics: Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Feasibility Studies; Female; Ferric Compounds; Gadolinium; Image Interpretation, Computer-Assisted; Inflammation; Magnetic Resonance Imaging; Multiple Sclerosis; Rats; Rats, Inbred Lew; Sensitivity and Specificity | 2004 |
Visual evoked potential is superior to triple dose magnetic resonance imaging in the diagnosis of optic nerve involvement.
Topics: Adult; Evoked Potentials, Visual; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Neurologic Examination; Optic Nerve; Optic Neuritis | 2004 |
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes.
Topics: Cohort Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Sensitivity and Specificity; Syndrome; Time Factors | 2006 |
Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.
Topics: Adult; Brain Diseases; Cohort Studies; Cross-Sectional Studies; Disability Evaluation; Female; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Predictive Value of Tests | 2005 |
Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
Topics: Adult; Age Factors; Aging; Brain; Encephalitis; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Risk Factors | 2005 |
Magnetic resonance imaging at 3.0 tesla detects more lesions in acute optic neuritis than at 1.5 tesla.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prospective Studies; Reproducibility of Results | 2006 |
Mononuclear subsets in the peripheral blood of multiple sclerosis patients in relation to results of brain gadolinium- enhancing imaging.
Topics: Adult; Brain; Flow Cytometry; Gadolinium; Humans; Immunohistochemistry; Lymphocyte Subsets; Lymphocytes; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Radiographic Image Enhancement | 2006 |
Magnetic resonance imaging findings in sudden sensorineural hearing loss.
Topics: Adult; Aged; Arachnoid Cysts; Audiometry, Pure-Tone; Brain; Cerebellum; Cochlea; Female; Gadolinium; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neuroma, Acoustic | 2006 |
Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
Topics: Adult; Brain; Chelating Agents; Contrast Media; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gadolinium; Humans; Image Enhancement; Injections, Intra-Arterial; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2007 |
MRI features of pediatric multiple sclerosis.
Topics: Adult; Central Nervous System Diseases; Child; Contrast Media; Encephalomyelitis, Acute Disseminated; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Nerve Fibers, Myelinated; Pediatrics; Predictive Value of Tests; Prognosis | 2007 |
Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis.
Topics: Adolescent; Adult; Contrast Media; Female; Gadolinium; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prospective Studies; Reproducibility of Results | 2008 |
Fluctuating corticosteroid-responsive auditory neuropathy/dyssynchrony is suggestive of central nervous system pathology.
Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Audiology; Audiometry, Pure-Tone; Central Nervous System Diseases; Child; Cochlear Nerve; Cyclophosphamide; Evoked Potentials, Auditory, Brain Stem; Female; Gadolinium; Hearing Loss, Unilateral; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin Sheath; Speech Discrimination Tests; Vestibulocochlear Nerve Diseases | 2007 |
Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile.
Topics: Adolescent; Adult; Brain; Cohort Studies; Contrast Media; Demyelinating Diseases; Early Diagnosis; Female; Follow-Up Studies; Gadolinium; Genetic Predisposition to Disease; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neurologic Examination; Optic Neuritis; Retrospective Studies; Risk Factors | 2008 |
Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Topics: Adult; Aged; Biomarkers; Brain; Contrast Media; Enzyme-Linked Immunosorbent Assay; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Nervous System Diseases; Osteopontin; Predictive Value of Tests; Sensitivity and Specificity | 2008 |
Does high field MRI allow an earlier diagnosis of multiple sclerosis?
Topics: Adult; Brain; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Follow-Up Studies; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination; Prospective Studies | 2008 |
Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter.
Topics: Adult; Brain Chemistry; Choline; Contrast Media; Creatine; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Phosphocreatine | 1995 |
Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination.
Topics: Adult; Disability Evaluation; Female; Gadolinium; Humans; Image Enhancement; Influenza, Human; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Vaccination | 1995 |
Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis | 1995 |
Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up.
Topics: Acute Disease; Adolescent; Adult; Aged; Brain; Contrast Media; Diagnosis, Differential; Drug Combinations; Encephalomyelitis; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Myelitis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Spinal Cord Diseases | 1995 |
Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images.
Topics: Adolescent; Adult; Aged; Blood-Brain Barrier; Brain; Cohort Studies; Contrast Media; Demyelinating Diseases; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetics; Middle Aged; Multiple Sclerosis; Myelin Sheath | 1995 |
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.
Topics: Antigens, CD; Antigens, Neoplasm; Brain; CD52 Antigen; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Glycoproteins; Humans; Lymphocyte Depletion; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1994 |
Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis.
Topics: Adult; Cerebral Cortex; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Radiographic Image Enhancement; Radionuclide Imaging | 1993 |
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Infant, Newborn; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy Trimester, Second; Puerperal Disorders | 1994 |
Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig.
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Encephalomyelitis, Autoimmune, Experimental; Gadolinium; Gadolinium DTPA; Guinea Pigs; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1993 |
[Cerebral magnetic resonance tomography in multiple sclerosis].
Topics: Adult; Blood-Brain Barrier; Brain; Disability Evaluation; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 1993 |
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
Topics: Adult; Brain; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prednisone; Recurrence; Remission, Spontaneous; Spine; Time Factors; Visual Acuity | 1993 |
Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis.
Topics: Adult; Blood-Retinal Barrier; Brain; Capillary Permeability; Contrast Media; Female; Fluorescein Angiography; Fundus Oculi; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Phlebitis; Prospective Studies; Recurrence; Retinal Diseases; Retinal Vein | 1996 |
A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Contrast Media; Disabled Persons; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recurrence; Sensitivity and Specificity; Severity of Illness Index; Time Factors | 1996 |
Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.
Topics: Adult; Brain; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Neurologic Examination; Recurrence; Remission, Spontaneous; Spinal Cord; Time Factors | 1996 |
Balo's concentric sclerosis. Report of two patients with magnetic resonance imaging follow-up.
Topics: Adult; Brain Diseases; Contrast Media; Diffuse Cerebral Sclerosis of Schilder; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Remission, Spontaneous | 1996 |
Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques.
Topics: Adult; Aged; Aged, 80 and over; Brain; Cell Adhesion; Encephalitis, Viral; Endothelium; Gadolinium; Humans; L-Selectin; Leukocytes; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Solubility | 1996 |
Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.
Topics: Adult; Brain; Cytokines; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 1996 |
Serum IgG to brain microvascular endothelial cells in multiple sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Autoantigens; Autoimmune Diseases; Blood-Brain Barrier; Brain; Cells, Cultured; Endothelium, Vascular; Female; Fluorescent Antibody Technique, Indirect; Gadolinium; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Multiple Sclerosis; Rats; Rats, Wistar; Umbilical Veins; von Willebrand Factor | 1996 |
Brain and spinal cord MR in benign multiple sclerosis: a follow-up study.
Topics: Adult; Brain Diseases; Disease Progression; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prospective Studies; Spinal Cord Diseases | 1996 |
Importance of magnetic resonance imaging and gadolinium enhancement.
Topics: Gadolinium; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis | 1996 |
Appropriateness of magnetic resonance imaging in sudden sensorineural hearing loss.
Topics: Adult; Aged; Audiometry, Pure-Tone; Cerebellar Neoplasms; Cerebellopontine Angle; Cranial Nerve Neoplasms; Female; Gadolinium; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Meningioma; Multiple Sclerosis; Neuroma, Acoustic; Vestibulocochlear Nerve | 1997 |
The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patients.
Topics: Adult; Female; Gadolinium; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; Remission, Spontaneous; Sensitivity and Specificity | 1997 |
Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis.
Topics: Adult; Contrast Media; Demyelinating Diseases; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetics; Multiple Sclerosis | 1997 |
Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
Topics: Adult; Biomarkers; Disease Progression; Female; Gadolinium; Humans; Intercellular Adhesion Molecule-1; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Sex Factors; Solubility; Vascular Cell Adhesion Molecule-1 | 1997 |
Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis.
Topics: Adult; Brain; Disease Progression; Female; Gadolinium; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Sensitivity and Specificity; Time Factors | 1997 |
Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
Topics: Adult; Brain; Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prospective Studies; Sensitivity and Specificity; Time Factors | 1997 |
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.
Topics: Adult; Brain; Contrast Media; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Observer Variation | 1997 |
Improvement of post-gadolinium contrast with magnetization transfer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds | 1997 |
Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR images.
Topics: Acute Disease; Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Gadolinium; Humans; Ibuprofen; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Pilot Projects; Treatment Outcome | 1997 |
Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.
Topics: Analysis of Variance; Brain; Education; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Observer Variation; Practice Guidelines as Topic | 1997 |
Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.
Topics: Adult; Anxiety; Corticotropin-Releasing Hormone; Cross-Sectional Studies; Depression; Dexamethasone; Encephalitis; Female; Gadolinium; Humans; Hypothalamo-Hypophyseal System; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Mood Disorders; Multiple Sclerosis; Pituitary-Adrenal System; Psychiatric Status Rating Scales | 1998 |
Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.
Topics: Adult; Aspartic Acid; Brain; Choline; Female; Gadolinium; Humans; Image Enhancement; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis | 1998 |
Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis.
Topics: Adult; Brain; C-Reactive Protein; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Nervous System Diseases; Recurrence; Serum Amyloid A Protein | 1998 |
A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: correlations with changes of T2 and magnetization transfer lesion loads.
Topics: Adult; Contrast Media; Disease Progression; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Multiple Sclerosis; Recurrence; Time Factors | 1998 |
Serial magnetization transfer imaging to characterize the early evolution of new MS lesions.
Topics: Adult; Blood-Brain Barrier; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin Sheath | 1998 |
Detecting new lesion formation in multiple sclerosis: the relative contributions of monthly dual-echo and T1-weighted scans after triple-dose gadolinium.
Topics: Adult; Brain; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Radiopharmaceuticals | 1998 |
Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging.
Topics: Adult; Brain; Disease Progression; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Recurrence; Regression Analysis; Statistics, Nonparametric | 1998 |
T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation.
Topics: Adult; Brain; Contrast Media; Disease Progression; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 1998 |
A serial study of new MS lesions and the white matter from which they arise.
Topics: Adult; Atrophy; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Nerve Fibers; Recurrence | 1998 |
Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity.
Topics: Adult; Brain; Female; Follow-Up Studies; Gadolinium; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prognosis | 1999 |
Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood-Brain Barrier; Capillaries; Child; Disease Progression; Female; Gadolinium; Gas Chromatography-Mass Spectrometry; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Recurrence | 1999 |
Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?
Topics: Adult; Brain; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 1999 |
Correlation between enhancing lesion number and volume on standard and triple dose gadolinium-enhanced brain MRI scans from patients with multiple sclerosis.
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 1999 |
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis.
Topics: Adolescent; Adult; Brain; Child; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 9; Middle Aged; Multiple Sclerosis; Multivariate Analysis; Recurrence; Reference Values; Regression Analysis; Tissue Inhibitor of Metalloproteinase-1 | 1999 |
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.
Topics: Adjuvants, Immunologic; Adult; Antibodies; Disability Evaluation; Female; Gadolinium; Humans; Intercellular Adhesion Molecule-1; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Longitudinal Studies; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Multiple Sclerosis; Recurrence; Solubility | 1999 |
Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images.
Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Observer Variation | 1999 |
[Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Recurrence; Statistics, Nonparametric | 1999 |
Distinct patterns of active and non-active plaques using texture analysis on brain NMR images in multiple sclerosis patients: preliminary results.
Topics: Adult; Brain; Discriminant Analysis; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Retrospective Studies; Sensitivity and Specificity | 1999 |
The sensitivity of thin-slice fast spin echo, fast FLAIR and gadolinium-enhanced T1-weighted MRI sequences in detecting new lesion activity in multiple sclerosis.
Topics: Adult; Brain; Female; Gadolinium; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Sensitivity and Specificity | 1999 |
Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Topics: Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis; Seasons | 2000 |
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.
Topics: Adolescent; Adult; Atrophy; Brain; Contrast Media; Corpus Callosum; Disease Progression; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Observer Variation; Reproducibility of Results; Severity of Illness Index; Time Factors | 2000 |
Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction.
Topics: Adult; Blood Volume; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds | 2000 |
A pilot study of the relationship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in multiple sclerosis.
Topics: Adult; Antioxidants; Blood-Brain Barrier; Brain; Female; Gadolinium; Genotype; Glutathione Transferase; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Oxidative Stress; Pilot Projects; Polymorphism, Genetic; Prognosis; Sex Factors | 2000 |
Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis.
Topics: Adrenal Cortex Hormones; Adult; Biomarkers; Brain; Creatinine; Disease Progression; Female; Gadolinium; Humans; Interferon-gamma; Macrophages; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Neopterin; Secondary Prevention; Time Factors | 2000 |
Multiple sclerosis and magnetic resonance imaging: advancement in linking the pictures with the progression.
Topics: Atrophy; Biomarkers; Blood-Brain Barrier; Brain; Disease Progression; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin Sheath; Neurons; Radioisotopes | 2001 |
[Intracranial tumor-like lesions in children and young adults with multiple sclerosis].
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Diagnosis, Differential; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Time Factors | 1992 |
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
Topics: Adult; Brain; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recurrence; Sensitivity and Specificity; Time Factors | 1992 |
Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.
Topics: Adult; Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Prognosis; Research Design | 1992 |
Outcome measures for clinical trials in multiple sclerosis.
Topics: Clinical Trials as Topic; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Treatment Outcome | 1992 |
Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy.
Topics: Adult; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pregnancy | 1992 |
Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.
Topics: Adult; Blood-Brain Barrier; Female; Gadolinium; Humans; Image Enhancement; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Recurrence; Remission, Spontaneous | 1991 |
[MRI of intracranial lesions].
Topics: Brain Abscess; Brain Diseases; Brain Neoplasms; Cerebrovascular Disorders; Contraindications; Gadolinium; Humans; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Multiple Sclerosis; Orbital Diseases; Sella Turcica | 1991 |
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.
Topics: Adult; Blood-Brain Barrier; Brain Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Kidney; Magnetic Resonance Imaging; Models, Biological; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Permeability; Time Factors | 1991 |
The longstanding MS lesion. A quantitative MRI and electron microscopic study.
Topics: Adult; Brain; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1991 |
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.
Topics: Blood-Brain Barrier; Brain; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Models, Biological; Models, Chemical; Models, Structural; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1990 |
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
Topics: Adolescent; Adult; Blood-Brain Barrier; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1990 |
Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1990 |
Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Brain; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Tomography, X-Ray Computed | 1987 |
Multiple sclerosis: gadolinium enhancement in MR imaging.
Topics: Adult; Aged; Contrast Media; Diatrizoate Meglumine; Female; Gadolinium; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Pentetic Acid; Tomography, X-Ray Computed | 1986 |
[Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Pentetic Acid | 1986 |